Cryoanalgesia for Phantom Limb Pain
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Cryoanalgesia for Phantom Limb Pain?
Research shows that cryoanalgesia, which uses cold temperatures to target nerves, can significantly reduce phantom limb pain. In one study, 3 out of 5 patients experienced a 90% or greater reduction in pain, and another study reported profound pain relief after limb amputation with no long-term pain.12345
Is cryoanalgesia safe for treating phantom limb pain?
How is the treatment Cryoanalgesia unique for phantom limb pain?
Cryoanalgesia is unique because it uses low temperatures to temporarily disable nerves, providing long-term pain relief without the need for ongoing medication. This method targets the peripheral nerves directly, which can lead to significant and lasting reduction in phantom limb pain, unlike traditional treatments that may not address the nerve-specific origin of the pain.12378
What is the purpose of this trial?
Investigators will evaluate preamputation cryoanalgesia on pain, mobility, opioid use and general physical and emotional disability using a pilot randomized trial design, to explore the amount and variability of improvement on those outcomes and to investigate the potentiality of conducting a future larger randomized controlled trial, which the investigators will assess quantitatively the benefits of cryoanalgesia.
Research Team
Alparslan Turan, MD
Principal Investigator
The Cleveland Clinic
Eligibility Criteria
This trial is for adults over 18 who are scheduled to have an amputation below the hip and including at least one bone in the foot. It's not suitable for those who don't meet these specific conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Cryoanalgesia
Participants receive preoperative cryoanalgesia to improve post-amputation outcomes
Postoperative Monitoring
Participants are monitored for phantom limb pain, mobility, and opioid consumption
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Cryoanalgesia
- Sham Cryoanalgesia
Cryoanalgesia is already approved in United States, European Union for the following indications:
- Chronic pain management
- Phantom limb pain
- Intercostal neuralgia
- Lumbar facet pain
- Trigeminal neuralgia
- Chronic pain management
- Phantom limb pain
- Intercostal neuralgia
- Lumbar facet pain
- Trigeminal neuralgia
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor
Pacira Pharmaceuticals, Inc
Industry Sponsor
Dr. Jonathan Slonin
Pacira Pharmaceuticals, Inc
Chief Medical Officer since 2020
BSc in Biomedical Engineering and MD from University of Miami, MBA from George Washington University
Frank D. Lee
Pacira Pharmaceuticals, Inc
Chief Executive Officer since 2024
BSc in Chemical Engineering from Vanderbilt University, MBA from Wharton Graduate School of Business